SEC Form 4 · accession 0001022079-19-000050
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gail R Wilensky
Director
Period of report
Feb 22, 2019
Accepted (ET)
Feb 25, 2019 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 22, 2019 | M | 8,000 | $51.55 | A | 34,604 | D | |
| Common StockF1 | Feb 22, 2019 | S | 8,000 | $87.777 | D | 26,604 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $51.55 | Feb 22, 2019 | M | 8,000 | D | — | May 14, 2019 | Common Stock | 8,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $87.77 to $87.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.